Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of IV VIS410 in Addition to Oseltamivir Compared With Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support

NCT03040141 is registered in ClinicalTrials.gov with Visterra, Inc. as lead sponsor.

NCT NCT03040141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03040141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of IV VIS410 in Addition to Oseltamivir Compared With Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support
Lead sponsor
Visterra, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 3, 2018
Completion date
November 22, 2018
Enrollment
89 (actual)
Sites
114

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a